Phenylglycine derivatives can act as agonists or antagonists at different metabotropic glutamate receptor (mGluR) subtypes, including subtypes sensitive to l -2-amino-4-phosphonobutyric acid (L-AP4). We examined the pharmacology of four phenylglycines at L-AP4 receptors in ON bipolar cells of the amphibian retina in situ . As previously shown for S-4-carboxy-3-hydroxyphenylglycine (S-4C3H-PG) (Thoreson W. B. and Miller R. F., J. Gen. Physiol . 103 , 1019–1034, 1994), whole cell recordings indicate that S -3-carboxy-4hydroxyphenylglycine (S-3C4H-PG) and S-4-carboxyphenylglycine (S-4C-PG) are L-AP4 receptor agonists in retina. Concentration-response curves for these compounds were obtained using the b-wave of the electroretinogram (ERG) as an assay for ON bipolar cell activity. The rank-order potency and IC 50 values obtained were: S-4C-PG (204 μM) > S-4C3H-PG (399 μM) ⩾ S-3C4H-PG (558 μM). At 1 mM, RS - α -methyl4-carboxyphenylglycine (RS-M4C-PG) suppressed the b-wave by less than 20%. This weak effect is attributed to agonist actions of RS-M4C-PG. The agonist actions of phenylglycines in retina are different from their effects at L-AP4 receptors in spinal cord or the expressed L-AP4-sensitive receptor subtype, mGluR4 (Kemp et al, Eur. J. Pharmac. Molec. Pharmac. , 266 , 187–192, 1994; Thomsen et al., Eur. J. Pharmac. Molec. Pharmac. , 267 , 77–84, 1994; Hayashi et al., J. Neurosci. , 14 , 3370–3377, 1994). The results are therefore consistent with the proposal that there are multiple L-AP4-sensitive mGluR sybtypes and indicate that phenylglycine derivatives may be useful for pharmacologically discriminating among these sybtypes.
Neuropharmacology – Elsevier
Published: Jan 1, 1995
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera